Science Magazine: Vitamin B3 Modulates Mitochondrial Vulnerability and Prevents Glaucoma in Aged Mice

Screen Shot 2017-12-06 at 3.36.09 PM.png

Interesting piece in Science Magazine that looks at how Vitamin B3 may be beneficial in Glaucoma prevention. From the article:

Glaucomas are neurodegenerative diseases that cause vision loss, especially in the elderly. The mechanisms initiating glaucoma and driving neuronal vulnerability during normal aging are unknown. Studying glaucoma-prone mice, we show that mitochondrial abnormalities are an early driver of neuronal dysfunction, occurring before detectable degeneration. Retinal levels of nicotinamide adenine dinucleotide (NAD+, a key molecule in energy and redox metabolism) decrease with age and render aging neurons vulnerable to disease-related insults. Oral administration of the NAD+ precursor nicotinamide (vitamin B3), and/or gene therapy (driving expression of Nmnat1, a key NAD+-producing enzyme), was protective both prophylactically and as an intervention. At the highest dose tested, 93% of eyes did not develop glaucoma. This supports therapeutic use of vitamin B3 in glaucoma and potentially other age-related neurodegenerations.

If you're interested in reading the article in full, you can purchase it at: